Dulaglutide‐combined basal plus correction insulin therapy contributes to ideal glycemic control in non‐critical hospitalized patients

AIMS/INTRODUCTION: We investigated whether dulaglutide (DU)‐combined conventional insulin therapy is beneficial for glycemic control in non‐critically ill hospitalized patients with type 2 diabetes. MATERIALS AND METHODS: This study was a prospective, randomized controlled pilot study. Participants...

Descripción completa

Detalles Bibliográficos
Autores principales: Fushimi, Nobutoshi, Shibuya, Takashi, Yoshida, Yohei, Ito, Shun, Hachiya, Hiroki, Mori, Akihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6944833/
https://www.ncbi.nlm.nih.gov/pubmed/31168938
http://dx.doi.org/10.1111/jdi.13093

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6944833/
https://www.ncbi.nlm.nih.gov/pubmed/31168938
http://dx.doi.org/10.1111/jdi.13093

Ejemplares similares